Clinical trials
Phase 3 Nervous System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
71 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 3 |
| 2010 | 5 |
| 2011 | 8 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Terminated | 12 |
| Active, not recruiting | 9 |
| Recruiting | 5 |
| Withdrawn | 3 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vanda Pharmaceuticals | 5 |
| AbbVie | 4 |
| Eli Lilly and Company | 3 |
| GenSight Biologics | 3 |
| PTC Therapeutics | 3 |
| AstraZeneca | 2 |
| Auspex Pharmaceuticals, Inc. | 2 |
| GlaxoSmithKline | 2 |
| Hospira, now a wholly owned subsidiary of Pfizer | 2 |
| Ipsen | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nervous System Diseases | 71 |
| Central Nervous System Diseases | 24 |
| Brain Diseases | 19 |
| Neurodegenerative Diseases | 19 |
| Mental Disorders | 16 |
| Dementia | 13 |
| Genetic Diseases, Inborn | 13 |
| Alzheimer Disease | 12 |
| Neuromuscular Diseases | 10 |
| Genetic Diseases, X-Linked | 9 |
Trials
Showing 51 to 71 of 71. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.